Browsing Topic

pharma

55 posts
Image of the Nasodine nasal spray product

The world needs Nasodine: Here’s why…

With the ongoing parade of pandemic threats, a tappable market for Firebrick Pharma's Nasodine isn’t going…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Looking ahead to a year of intriguing investment opportunities

The New Year brings renewed energy, exciting opportunities, and the promise of growth. But will the…
Mosquito on human skin

Island enrols first subjects for Phase 2b clinical trial for dengue fever drug

Island Pharmaceuticals has enrolled its first four participants in a Phase 2b clinical trial to test…
3D image of two human kidneys

Dimerix inks agreement for development, commercialisation of kidney disease drug in Japan

Dimerix Ltd has signed an exclusive agreement with FUSO Pharmaceutical Industries in relation to its candidate…
Myelofibrosis cells in blood flow

Clinical trial data for MF candidate proves promising for Syntara

Syntara Ltd has reported positive interim results from its Phase 2 trial to test the efficacy…
The Market Online Video

Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial

Recce Pharmaceuticals Ltd has secured approval for a Phase 3 trial on its treatment candidate to…
Medical imaging of the human heart

Monash tests show strong cardioprotective qualities for Algorae drug candidate

Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
AI image of molecular structure

Race identifies 39 new molecules with potential to inhibit cancer-associated protein

Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University…
AI image of a medical researcher

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Radiopharm Theranostics Ltd has received approval to extend its Phase 1 trial of Lu-RAD204 to five…